Abstract:CONTEXT: <AbstractText Label="CONTEXT">Echinacoside (ECH) is a natural anti-cancer compound and is of great value in cancer treatment. However, the mechanism underlying this effect on breast cancer (BC) was unclear.</AbstractText>OBJECTIVE: <AbstractText Label="OBJECTIVE">To explore the mechanism of ECH treating BC by network pharmacology and experimental validation.</AbstractText>MATERIALS & METHODS: <AbstractText Label="MATERIALS &amp; METHODS">Several databases were searched to screen potential targets of ECH and obtain information on targets related to BC. STRING was applied to construct a Protein-protein interaction (PPI) network. DAVID was applied for Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Gene Expression Profiling Interactive Analysis (GEPIA) was searched for the relationship between the expression profile and overall survival of major targets in normal breast and BC tissues. Finally, the results of network pharmacology analysis were validated by experiments.</AbstractText>RESULTS: <AbstractText Label="RESULTS">Seventeen targets of ECH overlapped with targets in BC. Ten hub targets were determined through PPI. By GO and KEGG analysis 15 entries and 25 pathways were obtained, in which phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), hypoxia inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF) played greater roles. Validation of key targets in the GEPIA database showed that PIK3R1 and PIK3CD remained consistent with the results of the study. Experiments in vitro showed ECH inhibited proliferation, induced apoptosis and reduced mRNA levels and protein expression of PI3K, AKT, hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor A (VEGFA) in MCF-7 cells. Furthermore, experiments in vivo revealed that ECH significantly reduced tumor growth, promoted apoptosis and decreased the related mRNA levels and protein expression, suggesting ECH works on BC by regulating PI3K/AKT/HIF-1α/VEGF signaling pathway.</AbstractText>DISCUSSION & CONCLUSION: <AbstractText Label="DISCUSSION &amp; CONCLUSION">In summary, ECH played an important role in anti-BC by regulating PI3K/AKT/HIF-1α/VEGF signaling pathway. Furthermore, ECH had multi-target and multi-pathway effects, which may be a promising natural compound for treating BC.</AbstractText>

Echinacoside inhibits the proliferation, migration, invasion and angiogenesis of ovarian cancer cells through PI3K/AKT pathway

Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis

Icariin Attenuates the Tumor Growth by Targeting Mir-1-3p/tnks2/wnt/β-catenin Signaling Axis in Ovarian Cancer

Echinacoside regulates PI3K/AKT/HIF-1α/VEGF cross signaling axis in proliferation and apoptosis of breast cancer

Study on the Inhibitory Effects of Esculentoside A on Cervical Cancer Through PI3K/AKT/mTOR Signaling Pathway in Vitro and in Vivo Experiments

Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells

Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway.

Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells

Estrogen Stimulates the Invasion of Ovarian Cancer Cells Via Activation of the PI3K/AKT Pathway and Regulation of Its Downstream Targets E-cadherin and Α-Actinin-4

Echinacoside inhibits hepatocellular carcinoma progression by targeting the miR-30c-5p/FOXD1/KLF12 axis

Echinatin induces reactive oxygen species‐mediated apoptosis via JNK/p38 MAPK signaling pathway in colorectal cancer cells

The Natural Product Fucoidan Inhibits Proliferation and Induces Apoptosis of Human Ovarian Cancer Cells: Focus on the PI3K/Akt Signaling Pathway

Echinacoside exerts anti-tumor activity via the miR-503-3p/TGF-β1/Smad aixs in liver cancer

Study on the Regulatory Mechanism and Experimental Verification of Icariin for the Treatment of Ovarian Cancer Based on Network Pharmacology

Ginsenoside Rb1 Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells by Regulating Microrna-25

Synergistic Effect of Tripterygium Glycosides and Cisplatin on Drug-Resistant Human Epithelial Ovarian Cancer Via ILK/GSK3β/Slug Signal Pathway.

Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression

Effect of Sea Cucumber Glycosides on Ovarian Cancer Cell Line SKOV3: an in Vitro and in Silico Study

The Effects of Genistein on Epidermal Growth Factor Receptor Mediated Signal Transduction Pathway in Human Ovarian Carcinoma Cells Lines SKOV3 and Its Xenograft in Nude Mice

Endostar Blocks the Metastasis, Invasion and Angiogenesis of Ovarian Cancer Cells

Osthole Inhibits the PI3K/AKT Signaling Pathway Via Activation of PTEN and Induces Cell Cycle Arrest and Apoptosis in Esophageal Squamous Cell Carcinoma.